Responses
Poster Presentations
Rheumatoid arthritis - other biologic treatment
SAT0166 An Analysis of Laboratory Results from 2 Randomized, Double-Blind Studies of Sirukumab in Patients with Active Rheumatoid Arthritis Refractory To Disease-Modifying Anti-Rheumatic Drug Treatment
Compose a Response to This Article
Other responses
No responses have been published for this article.